Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

NCT00003700 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

163

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: G-CSF
DRUG: asparaginase
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: daunorubicin hydrochloride
DRUG: leucovorin calcium
DRUG: mercaptopurine
DRUG: methotrexate
DRUG: prednisone
DRUG: vincristine sulfate
DRUG: Allopurinol

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]